Published in Biochem Pharmacol on June 15, 1983
Relaxing actions of procaterol, a beta 2-adrenoceptor stimulant, on smooth muscle cells of the dog trachea. Br J Pharmacol (1988) 1.11
Pre- and post-junctional actions of procaterol, a beta 2-adrenoceptor stimulant, on dog tracheal tissue. Br J Pharmacol (1988) 0.94
Genome sequence of the plant pathogen Ralstonia solanacearum. Nature (2002) 6.23
Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet (2000) 4.34
International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev (1998) 2.30
Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study. J Clin Endocrinol Metab (1999) 2.07
Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut (1998) 1.98
Long-term results of growth hormone treatment in France in children of short stature: population, register based study. BMJ (1997) 1.81
Pancreas divisum: evaluation with secretin-enhanced magnetic resonance cholangiopancreatography. Gastrointest Endosc (2001) 1.77
Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas. Med Pediatr Oncol (2000) 1.66
Secretion of hydrolases by perfused fragments of rat pancreas: effect of calcium. Am J Physiol (1971) 1.62
A comparison of Ultraflex Diamond stents and Wallstents for palliation of distal malignant biliary strictures. Am J Gastroenterol (2000) 1.60
A novel class of calcium-entry blockers: the 1[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines. J Med Chem (1992) 1.59
Feasibility of intracoronary beta-irradiation to reduce restenosis after balloon angioplasty. A clinical pilot study. Circulation (1997) 1.55
Endoscopic treatment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy (2012) 1.55
Endoscopic pancreatic drainage in chronic pancreatitis associated with ductal stones: long-term results. Gastrointest Endosc (1996) 1.53
The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut (2002) 1.50
Does a radiolabelled ligand bind to a homogeneous population of non-interacting receptor sites? Trends Pharmacol Sci (1995) 1.50
The wirsungorrhagies: causes and management in 14 patients. Endoscopy (1998) 1.46
Randomized evaluation of six French voda-type guiding catheters for left coronary artery balloon angioplasty. Cathet Cardiovasc Diagn (1995) 1.46
Plastic and metal stents for postoperative benign bile duct strictures: the best and the worst. Gastrointest Endosc (1998) 1.46
Localization of transforming growth factor beta 1 and its latent binding protein in human chronic pancreatitis. Gastroenterology (1995) 1.44
New drug binding sites in Ca2+ channels. Trends Pharmacol Sci (1995) 1.39
Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology (1995) 1.37
Colonoscopic snare polypectomy: analysis of 1485 resections comparing two types of current. Gastrointest Endosc (1992) 1.32
Ralstonia solanacearum produces hrp-dependent pili that are required for PopA secretion but not for attachment of bacteria to plant cells. Mol Microbiol (2000) 1.31
Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Cancer Res (2000) 1.29
Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain. Mol Pharmacol (1990) 1.28
Endoscopic treatment of gastric outlet obstruction caused by a gallstone (Bouveret's syndrome) after extracorporeal shock-wave lithotripsy. Endoscopy (1997) 1.27
Transforming growth factor beta promotes development of fibrosis after repeated courses of acute pancreatitis in mice. Gastroenterology (1996) 1.26
In vitro action of bombesin and bombesin-like peptides on amylase secretion, calcium efflux, and adenylate cyclase activity in the rat pancreas: a comparison with other secretagogues. J Clin Invest (1976) 1.25
Stenting in severe chronic pancreatitis: results of medium-term follow-up in seventy-six patients. Endoscopy (1991) 1.20
The stimulus-secretion coupling of glucose-induced insulin release. XLVI. Physiological role of L-glutamine as a fuel for pancreatic islets. Mol Cell Endocrinol (1980) 1.19
In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction. Cancer Res (1992) 1.17
Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci U S A (1994) 1.16
Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut (1998) 1.16
In vitro properties of a high affinity selective antagonist of the VIP1 receptor. Peptides (1997) 1.15
SR 33589, a new amiodarone-like antiarrhythmic agent: anti-adrenoceptor activity in anaesthetized and conscious dogs. Eur J Pharmacol (1995) 1.15
Two basic residues of the h-VPAC1 receptor second transmembrane helix are essential for ligand binding and signal transduction. J Biol Chem (2001) 1.14
Improvement of left ventricular contraction and relaxation synchronism after recanalization of chronic total coronary occlusion by angioplasty. J Am Coll Cardiol (1987) 1.14
Binding properties of nine 4-diphenyl-acetoxy-N-methyl-piperidine (4-DAMP) analogues to M1, M2, M3 and putative M4 muscarinic receptor subtypes. Br J Pharmacol (1992) 1.14
SR 33589, a new amiodarone-like antiarrhythmic agent: electrophysiological effects in anesthetized dogs. J Cardiovasc Pharmacol (1995) 1.13
In vitro interactions of gastrointestinal hormones on cyclic adenosine 3':5'-monophosphate levels and amylase output in the rat pancreas. Gastroenterology (1975) 1.12
Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion. Circulation (1987) 1.11
Deletion of mitochondrial DNA in a case of early-onset diabetes mellitus, optic atrophy, and deafness (Wolfram syndrome, MIM 222300). J Clin Invest (1993) 1.10
Evidence of a specific complex between adriamycin and negatively-charged phospholipids. Biochim Biophys Acta (1980) 1.09
Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites. Mol Pharmacol (1982) 1.09
Demonstration of biological activity of brain gastrin-like peptidic material in the human: its relationship with the COOH-terminal octapeptide of cholecystokinin. Proc Natl Acad Sci U S A (1978) 1.08
Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC(2) receptor. Peptides (2000) 1.08
Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. J Cardiovasc Pharmacol (1995) 1.07
Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours. Gut (1995) 1.07
Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study. J Clin Endocrinol Metab (2000) 1.07
Biliary pleural fistula as a complication of radiofrequency ablation for liver metastasis. Acta Chir Belg (2004) 1.06
Long-term outcome after pancreatic stenting in severe chronic pancreatitis. Endoscopy (2005) 1.05
Pancreatic secretion of total protein and of three hydrolases collected in healthy subjects via duodenoscopic cannulation. Effects of secretin, pancreozymin, and caerulein. Gastroenterology (1975) 1.05
The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors. Peptides (1996) 1.04
Development of high affinity selective VIP1 receptor agonists. Peptides (1997) 1.04
Contribution of the second transmembrane helix of the secretin receptor to the positioning of secretin. FEBS Lett (1998) 1.04
Activation of p38 and p42/44 MAP kinase in neuropathic pain: involvement of VPAC2 and NK2 receptors and mediation by spinal glia. Mol Cell Neurosci (2005) 1.03
Exocrine pancreas: evidence for topographic partition of secretory function. Science (1975) 1.03
Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist. Endocrinology (1985) 1.03
Liquid-based cytology for primary cervical cancer screening: a multi-centre study. Br J Cancer (2001) 1.02
Rat pancreatic hydrolases from birth to weaning and dietary adaptation after weaning. Am J Physiol (1971) 1.02
H1 antagonists: receptor affinity versus selectivity. Inflamm Res (2003) 1.02
In-vivo measurements of wall shear stress in human coronary arteries. Coron Artery Dis (2000) 1.01
Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board. Acta Paediatr Suppl (1999) 1.01
Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes. Eur J Pharmacol (1989) 1.01
Failure of non-surgical procedures to treat gastric trichobezoar. Endoscopy (1989) 1.01
The stimulus-secretion coupling of amino acid-induced insulin release. Metabolic interaction of L-glutamine and 2-ketoisocaproate in pancreatic islets. Biochim Biophys Acta (1981) 1.00
SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats. J Cardiovasc Pharmacol (1995) 1.00
Pancreas divisum: congenital anatomic variant or anomaly? Contribution of endoscopic retrograde dorsal pancreatography. Gastroenterology (1985) 1.00
Role of charged amino acids conserved in the vasoactive intestinal polypeptide/secretin family of receptors on the secretin receptor functionality. Peptides (1999) 0.99
Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes. Endocrinology (1985) 0.99
Effect of increasing degrees of ischemic injury on myocardial oxidative metabolism early after reperfusion in isolated rat hearts. Circ Res (1991) 0.99
Chronic pancreatitis: evaluation of pancreatic exocrine function with MR pancreatography after secretin stimulation. Radiology (2000) 0.99
Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation. Endoscopy (2004) 0.98
Effect of a high-fat diet on obese-hyperglycaemic and non-obese Bar Harbor mice. Diabetologia (1971) 0.98
Factors regulating biosynthesis, intracellular transport and secretion of amylase and lipase in the rat exocrine pancreas. Horm Metab Res (1971) 0.98